FDA Expands Emergency Use Authorization for Pfizer-BioNTech’s COVID-19 Vaccine
jmbknews.substack.com
by Legis Politica ™ - In what has become a modern trend, The U.S. Food & Drug Administration has issued further revisions and amendments to Pfizer-BioNTech’s Emergency Use Authorization, which now includes all children twelve to fifteen years old. In addition, the FDA revision includes eligibility for immunocompromised children aged five to eleven, who may now begin receiving booster shots. Lastly, the FDA has reduced the time in between primary injections and booster shots to five months.
FDA Expands Emergency Use Authorization for Pfizer-BioNTech’s COVID-19 Vaccine
FDA Expands Emergency Use Authorization for…
FDA Expands Emergency Use Authorization for Pfizer-BioNTech’s COVID-19 Vaccine
by Legis Politica ™ - In what has become a modern trend, The U.S. Food & Drug Administration has issued further revisions and amendments to Pfizer-BioNTech’s Emergency Use Authorization, which now includes all children twelve to fifteen years old. In addition, the FDA revision includes eligibility for immunocompromised children aged five to eleven, who may now begin receiving booster shots. Lastly, the FDA has reduced the time in between primary injections and booster shots to five months.